595 related articles for article (PubMed ID: 11238045)
1. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
Kim KS; Denton MD; Chandraker A; Knoflach A; Milord R; Waaga AM; Turka LA; Russell ME; Peach R; Sayegh MH
Am J Pathol; 2001 Mar; 158(3):977-86. PubMed ID: 11238045
[TBL] [Abstract][Full Text] [Related]
2. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.
Russell ME; Hancock WW; Akalin E; Wallace AF; Glysing-Jensen T; Willett TA; Sayegh MH
J Clin Invest; 1996 Feb; 97(3):833-8. PubMed ID: 8609241
[TBL] [Abstract][Full Text] [Related]
3. Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.
Chandraker A; Azuma H; Nadeau K; Carpenter CB; Tilney NL; Hancock WW; Sayegh MH
J Clin Invest; 1998 Jun; 101(11):2309-18. PubMed ID: 9616202
[TBL] [Abstract][Full Text] [Related]
4. Blockade of CD28/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type1-dominated immune response.
Tikkanen JM; Lemström KB; Koskinen PK
Am J Respir Crit Care Med; 2002 Mar; 165(5):724-9. PubMed ID: 11874822
[TBL] [Abstract][Full Text] [Related]
5. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
[TBL] [Abstract][Full Text] [Related]
6. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
Bolling SF; Lin H; Wei RQ; Turka LA
J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
[TBL] [Abstract][Full Text] [Related]
7. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
Onodera K; Chandraker A; Schaub M; Stadlbauer TH; Korom S; Peach R; Linsley PS; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 1997 Aug; 159(4):1711-7. PubMed ID: 9257832
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
Newell KA; He G; Guo Z; Kim O; Szot GL; Rulifson I; Zhou P; Hart J; Thistlethwaite JR; Bluestone JA
J Immunol; 1999 Sep; 163(5):2358-62. PubMed ID: 10452966
[TBL] [Abstract][Full Text] [Related]
9. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
Azuma H; Chandraker A; Nadeau K; Hancock WW; Carpenter CB; Tilney NL; Sayegh MH
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12439-44. PubMed ID: 8901600
[TBL] [Abstract][Full Text] [Related]
10. Induction of regulatory cells and control of cellular but not vascular rejection by costimulation blockade in hamster-to-rat heart xenotransplantation.
Séveno C; Coulon F; Haspot F; Mérieau E; Renaudin K; Martinet B; Vanhove B
Xenotransplantation; 2007 Jan; 14(1):25-33. PubMed ID: 17214702
[TBL] [Abstract][Full Text] [Related]
11. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts.
Glysing-Jensen T; Räisänen-Sokolowski A; Sayegh MH; Russell ME
Transplantation; 1997 Dec; 64(12):1641-5. PubMed ID: 9422395
[TBL] [Abstract][Full Text] [Related]
12. Costimulation and its role in organ transplantation.
Bluestone JA
Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
[TBL] [Abstract][Full Text] [Related]
13. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.
Chandraker A; Russell ME; Glysing-Jensen T; Willett TA; Sayegh MH
Transplantation; 1997 Apr; 63(8):1053-8. PubMed ID: 9133464
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
Via CS; Rus V; Nguyen P; Linsley P; Gause WC
J Immunol; 1996 Nov; 157(9):4258-67. PubMed ID: 8892665
[TBL] [Abstract][Full Text] [Related]
15. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
Salomon B; Bluestone JA
Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
[TBL] [Abstract][Full Text] [Related]
16. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
[TBL] [Abstract][Full Text] [Related]
17. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4.
Lakkis FG; Konieczny BT; Saleem S; Baddoura FK; Linsley PS; Alexander DZ; Lowry RP; Pearson TC; Larsen CP
J Immunol; 1997 Mar; 158(5):2443-8. PubMed ID: 9036995
[TBL] [Abstract][Full Text] [Related]
18. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen.
Schaub M; Stadlbauer TH; Chandraker A; Vella JP; Turka LA; Sayegh MH
J Am Soc Nephrol; 1998 May; 9(5):891-8. PubMed ID: 9596088
[TBL] [Abstract][Full Text] [Related]
19. The time course of CTLAIg effect on cardiac allograft rejection.
Bolling SF; Lin H; Turka LA
J Surg Res; 1996 Jun; 63(1):320-3. PubMed ID: 8661218
[TBL] [Abstract][Full Text] [Related]
20. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
